- Skip Navigation

Note: This message is displayed if (1) your browser is not standards-compliant or (2) you have you disabled CSS. Read our Policies for more information.

Indiana General Assembly
Senate Bill 0231


Search all legislative material from the 2001 Session.
General Assembly Home Page

Session Information

Complete Bill Listing

Get Acrobat Reader
You will need to download and install Acrobat Reader to view PDF documents.


Senate Bill 0231

ARCHIVE (2001)

Latest Information

DIGEST OF SB231 (Updated April 12, 2001 6:18 PM - DI 84)

Rx program. Establishes the Rx program to help provide discounted prescription drug prices to uninsured residents of Indiana. Requires the state department of health to submit an annual report to the legislative council on the enrollment and financial status of the Rx program each year. Allows a drug manufacturer or labeler that sells prescription drugs in Indiana through any state funded or state operated program to enter into a voluntary rebate agreement with the department that requires rebate payments to be made to the state for the Rx program each calendar quarter. Provides that the department may prompt a review of the prescription drug component of the state Medicaid program for drugs provided by a drug manufacturer or labeler that does not enter into a voluntary rebate agreement with the department. Requires the state department of health to make available certain information. Authorizes the state department to negotiate the amount of the voluntary rebate entered into by a manufacturer or labeler. Requires the voluntary rebate to take effect within a reasonable time. Establishes a formula for the state to use in calculating discount prices for drugs covered by the voluntary rebate agreement. Beginning July 1, 2002, requires a retail pharmacy to sell the drugs covered by the Rx program to participants in the program at the discounted price determined by the state department. Establishes a procedure for resolving discrepancies in rebate amounts. Allows the state department to audit a manufacturer or labeler to determine whether the price negotiated complies with certain requirements. Provides the state with remedies for a violation. Establishes the Rx dedicated fund, consisting of: (1) revenue from manufacturers and labelers who pay rebates; and (2) appropriations or allocations to the fund.
    Current Status:
     In Conference Committee
    >Latest Printing > (PDF)